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Abstract 
 
Schizophrenia is a disorder that affects 1% of the population and causes enormous 
deficits in functioning. The development of this disorder is through unclear 
mechanisms, yet studies suggest that genetics and dopamine processes play a 
major role in the manifestation of schizophrenia. This study considers the gene 
that encodes dopamine receptor D2 (DRD2) and how single nucleotide 
polymorphisms (SNPs) affect alternative splicing of the gene and the balance 
between the two different protein isoforms, Long (D2L) and Short (D2S). Four 
mutations (rs12363125 and rs2511521 from intron 5 and rs6275 and rs6277 from 
exon 7) were studied. Constructs were derived from extracted DNA from 
postmortem brain tissue of Brodmann’s Area 10 of deceased patients with 
schizophrenia and non-psychiatric comparison subjects. Enzyme digests and 
ligations of patient DNA were used to create constructs that have a spectrum of 
mutation combinations. Quantitative polymerase chain reaction (qPCR) analysis 
was used to measure the proportional expression of the different isoforms. A 
linear regression model with an r
2
of 0.255 showed that more than 25% of the 
variance in D2L to D2S expression ratios (L/S Ratios) were attributable to SNPs, 
and rs6275 and rs6277 were found to independently and significantly affect L/S 
Ratios expressed by cells, with p<0.001 and 0.048, respectively. 
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Advice to Future Honors Students 
 
Don’t choose a project on the basis that it is easy to do, nor a laboratory 
because of its convenience. Find out what makes you excited, something you 
actually want to discover, and then find a lab to suit you, not the other way 
around. Anticipation of results can be just as exciting as the ending of a novel if 
you choose well. 
v 
 
1 
 
I. Introduction 
 
Schizophrenia is a severely debilitating disorder that interferes with the ability 
to think logically, experience emotion, succeed socially, and recognize reality. 
Schizophrenia (SZ) affects the emotional and social functioning of 1% of the 
world’s population (Tsuang et al. 1997). There are many different types of 
schizophrenia. Some people experience psychosis, which is the manifestation of 
delusions or auditory or visual hallucinations. Another category of symptoms is 
extremely disorganized thinking and situationally inappropriate behavior. 
Alternatively, some individuals with schizophrenia may become extremely 
inactive with rigid movements and show inappropriate or total lack of emotion 
(National Institute of Mental Health 2009). SZ is identified as a public health 
concern due to its economic impact and prevalence (Rice 1999 and Goldner et al. 
2002). Because this disorder typically affects individuals from early adulthood 
until their death, it is incredibly important to identify its underlying mechanisms 
so it can be more effectively treated and, eventually, prevented. The aim of this 
study was to identify one aspect of a potential mechanism of development by 
focusing on how genetic elements of dopamine receptors may contribute to 
schizophrenia. 
 Genes have been shown to have a great contribution to the development of 
schizophrenia. The likelihood of developing schizophrenia increases dramatically 
if one is related to someone with the disorder; twin studies suggest a strong 
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genetic influence; the heritability of schizophrenia is estimated to be from 73% to 
90% (Sullivan et al. 2003).Other studies show that monozygotic twins of an 
affected individual have a 50% risk of developing SZ, dizygotic twins have 15% 
risk, and other first-degree relatives are at 10% risk (Faraone et al. 1999), which 
are all much higher than the 1% lifetime risk seen in the general population. 
Schizophrenia is thought to be derived from interactions among many genes 
(Risch 1990) and the environment (Gottesman and Shields 1982).  This study 
focuses on the genetic elements that are related to schizophrenia, specifically the 
ones involved in coordinating environmental interactions.  
The Dopamine Hypothesis is the belief that schizophrenic symptoms are a 
result of excess dopamine in the brain, illustrated in the experiments of Schmidt 
and Beninger (2006). Dopamine (DA) is a neurotransmitter that functions in 
motivation and reward, mood regulation, attention, working memory, and 
voluntary movement, all related to schizophrenia symptoms. DA has been 
implicated in many other neurological and psychiatric disorders including 
Parkinson’s disease, attention-deficit hyperactivity disorder (ADHD), and drug 
abuse. Schizophrenic patients have been found to have elevated presynaptic 
dopamine synthesis and availability (Howes and Kapur 2009). Medications that 
target the dopamine receptor D2 (DRD2) are the most effective for treating 
schizophrenia symptoms (Seeman 2006). Kestler has clarified this phenomenon 
by finding that dysregulation and dysfunction of D2 receptors occur in the brains 
of schizophrenic patients (Kestler et al. 2001), further justifying our research in 
dopaminergic pathways. 
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 Several mutations in the DRD2 gene have been previously associated with 
schizophrenia. When a mutation causes an amino-acid substitution in the protein, 
the disruption is obvious. However, many SZ-associated mutations are located on 
non-coding regions (introns) or are silent mutations (do not cause amino acid 
substitution). It is important to not dismiss these “silent” mutations since these are 
the elements that may bind DNA-binding proteins and RNA-binding proteins and 
thus coordinate transcription, RNA splicing, and translation. RNA must undergo 
several processes before it can be translated into a protein.  One of these steps is 
splicing; pre-mRNA molecules contain exons, which are segments of genetic 
sequence used directly for protein synthesis, and introns, whose functions are 
currently not well understood. During splicing, introns and some exons are 
removed from the molecule; the differential removal of exons causes different 
variants or isoforms of the RNA, which, subsequently, encodes different proteins. 
This process is modulated by alternative splicing regulator proteins (ASRs) that 
bind to regions surrounding segments that are to be included or removed from the 
pre-mRNA. Mutations may alter binding motifs of different ASRs that might 
cause a shift in the quantities of different protein isoforms. 
In DRD2, a long isoform (D2L) of the protein is made which includes 
exon 6, whereas a short isoform (D2S) has exon 6 excluded from the molecule via 
alternative splicing (Bertolino et al. 2009).  The D2S is a presynaptic autoreceptor 
associated with biosynthesis of dopamine and dopamine reuptake (Lindgren et al. 
2003) and thus attenuates the DA signal. D2L is a postsynaptic receptor (Khan et 
al. 1998) and propagates the DA signal. DRD2 density has shown significant 
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effects ton mouse working memory (Kellendonk et al. 2006). Furthermore, 
functional magnetic  resonance imaging (fMRI) studies in humans have shown 
that in patients that had decreased D2S expression, working memory performance 
declined (Zhang et al. 2007); these data are interesting for the implications of this 
experiment because schizophrenic patients have abnormal working memory. 
Studies in Dr. Stephen Glatt’s laboratory indicated that a single nucleotide 
polymorphism(SNP) in intron 6 of DRD2 is associated with schizophrenia and 
splicing (Glatt et al 2003). The rs1076560 allele shows highly significant 
evidence for association with schizophrenia under two models of inheritance 
(Glatt, S. submitted). There are alternative splicing regulators that are affected by 
rs1076560 because it alters their binding sites (Li et al. 2007). This allele has been 
found to influence the production of different forms of mRNA via alternative 
splicing by causing a shift in the expression ratios of D2S and D2L splice 
variants, where more D2L mRNA is expressed in the presence of the 
schizophrenia-risk allele. This is consistent with the dopamine hypothesis; if there 
are fewer D2S receptors regulating the presence of DA in the synapse, one would 
expect there to be extra dopaminergic activity. There is also an association of 
greater fMRI activity of the striatum and prefrontal cortex during working 
memory for those with the risk-conferring T allele of rs1076560 (Zhang et al. 
2007). 
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Genetic association results from a family-based association study of 
DRD2 polymorphisms in Han Chinese families from Taiwan implicated 
mutations in the intron 5 to exon 7 region as influencing risk for schizophrenia 
(Glatt, SJ et al. 2009). Others have found these same mutations to contribute to 
changes in the ratio of long to short DRD2 isoforms (Zhang 2007).This study was 
designed to pinpoint the precise mutations that have been found to be associated 
with schizophrenia in the intron 5 to exon 7 region of DRD2 that result in a high 
ratio of D2L to D2S expression in order to clarify the factors that alter splicing 
through different interactions with ASRs at these loci. My hypothesis is that these 
SNPs increase susceptibility to schizophrenia by causing splicing imbalances. 
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II. Material and Methods 
 
DNA Sample Preparations. Postmortem brain tissue (PMB) of patients 
with schizophrenia and controls was provided by Harvard Brain Tissue Resource 
Center (Belmont, MA) with consent of the patients’ families. QIAgen (Valencia, 
CA) Allprep procedures and kit were used to extract DNA. 30mg of Broadman’s 
Area 10 tissue from the PMB was lysed with 600µl of Buffer RLT Plus. The 
lysate was homogenized via QIAshredder. 700µl of 70% ethanol, cell contents 
and 500µl of Buffer AW1 were added to spin columns to separate out DNA from 
other contaminants. Buffer AW2 was added in 500µl volumes to wash columns. 
DNA was eluted with 100µl Buffer EB. 
 DNA was amplified via polymerase chain reaction with DRD2 e5-e7 
forward and reverse primers (Figure 1).This procedure utilized Phusion High-
Fidelity PCR kits from New England Biolabs (Ipswich, MA). To 10µl of template 
DNA, 10µl of 5x Phusion Master Mix, 1µl 10mM dNTPs, 1µl DMSO, 0.5µl of 
DNA Polymerase, 1µl of Mg
2+
 at 50mM, and 100µM of each primer were added 
to PCR. Using a MJ Research Peltier Thermocycler 225 from Harlow Scientific 
(Arlington, MA) the following incubation steps were completed: denaturing step 
for 30s at 98
o
C, 30 cycles of denaturing at 98
o
C for 10s, annealing at 60
o
C for 20s 
and extension steps at 72
o
C for 90s, and a final step at 72
o
C for 10 minutes. The 
reaction was then run on a 0.75% agarose gel to confirm successful amplification. 
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The amplified DNA region was then inserted into a pcDNA 3.1 vector 
from Invitrogen (Grand Island, NY). First, both the DNA and vector were 
digested using 1µleach of HindIII and XhoI in 5µl 10x Buffer 2, and 0.5µlof 
BSA. (All reagents were from New England Biolabs). The reaction was incubated 
at 37
o
C for 1 hour and ran on a 0.75% agarose gel. 
Using T4 DNA Ligase Kit from Invitrogen, cut DNA inserts and 
vectorswere ligated. Reactions were conducted with 4µl of 5x ligase reaction 
buffer, 0.1µl of T4 DNA ligase, and brought to a total volume of 20µl via addition 
of water. All water used in procedures is autoclaved, distilled, RNAse, DNAse, 
and Protease free water from Acros Organics of Thermo Fisher Scientific (New 
Jersey). The reaction was held at room temperature for 10 minutes.  
Minipreps of the ligation reaction were made to amplify the quantity of 
DNA. First, 2µl of the reaction was added to 50µl of Top 10 Competent cells (e. 
coli) from Invitrogen. To complete this transformation, reactions were incubated 
on ice for 30 minutes, heat shocked at 42
o
C for 30s, returned to ice for 2 minutes, 
and then added to SOC (Super Optimal Broth with Catabolite repression) 
medium. Cells were incubated at 37oC at 250rpm for 1 hour, and plated on agar 
with Ampicillin antibiotic (at 100µg per ml) to grow overnight. Using QIAgen 
Plasmid DNA Miniprep kit, the DNA constructs were sequestered from the 
transformed bacterial colonies.Cells were suspended in 250µl of Buffer P1 and 
lysed by 250µl of Buffer P2. 350µl of Buffer N3 and cell contents were added to 
QIAprep spin column and washed with 500µl of Buffer PB and 750µl of Buffer 
PE. DNA was eluted twice with 40µl of water.  
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Sequencing of these products, and all others, wasdone by Genewiz (South 
Plainfield, NJ).Samples were sent with 10µl of 80ng/µl of DNA sample and 5µl 
of 4µM of primer. Results were analyzed using Geneious Pro software (New 
Zealand). 
Creation of Constructs. Patient constructs were digested with BamHI 
and XhoI restriction enzymes from New England Bio Labs (NEB) in Buffer 4 
supplemented with bovine serum albumin. Reaction volumes were brought to 
50µl through the addition of water. Reactions were incubated at 37οC for 1 hour, 
and terminated by running on a 1.5% agarose gel for 90 minutes at 120V. 
 The subsequent digest was performed with BsaI restriction enzyme from 
NEB in the same conditions as the first digestion procedure, except a 1% agarose 
gel was used to terminate the reaction and separate fragments. 
 A spectrophotometer, NanoDrop 2000 from Thermoscientific was used to 
measure the DNA concentration of each fragment of DNA. Ligations were done 
using the Invitrogen T4 DNA Ligase Kit with the same protocol as described 
above. Reactions were performed with a 3:3:1 molar ratio of the two larger DNA 
fragments to the smallest DNA fragment. Reactions were conducted with 4µl of 
5x ligase reaction buffer, 1µl of T4 DNA ligase, and brought to a total volume of 
20µl via addition of water. Reactions were incubated at 37
o
C for 1 hour and 
transformed using the same procedure previously described. 
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Ligation reactions were plated on agar with ampicillin (100µg/1ml) via 
glass beads, and left to grow overnight while incubated at37οC and shaking at 
250rpm. Colonies were picked and grown in 4ml of LB broth with 40µl of 
ampicillin and grown overnight in the same conditions for QIAgen Minipreps.  
 Constructs were digested with Bsa I restriction enzyme using previous 
digestion protocols to identify potential successful ligation reactions. Those that 
matched the same gel profile of original patient constructs were selected to send 
out for sequencing.  
 Cell Culture and Transfection.  Human embryonic kidney cells were 
grown in 24 well plate in bovine serum free media and grown to 80% confluency. 
Cells were transfected using 1.6µl of FuGene transfection factor from Promega 
(Madison, WI) per reaction with 0.5 ug of DNA and media to bring the total 
reaction volume to 40µl. Each sample was transfected into twelve wells and kept 
separate throughout the experiment. Cells were left to grow for 48 hours at 37
o
C. 
 Harvesting RNA. Using QIAgen RNeasy kit, cells were lysed with 250µl 
Buffer RLT. 350µl of 70% ethanol was added, and all was added to an RNeasy 
spin column. 350µl RW1 buffer was added to wash RNA. 80µl of DNase 
Incubation Mix was added to the column to degrade possible DNA contaminants. 
The samples were washed again with 350µl Buffer RW1. 500µl Buffer RPE was 
added twice, and RNA was eluted with 40µl of water twice. RNA concentrations 
were found with a Synergy 2 plate reader from Biotek (Winooski, VT). 
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 RNA was then transformed to cDNA using a High Capacity cDNA 
Reverse Transcription kit from Applied Biosystems (Carlsbad, CA). 2µl 10x RT 
Buffer, 2µl Primers, 0.8µl 25x dNTPs, 1µl of Reverse Transcriptase and 4.2µl of 
water were added to 10µl of 100ng/µl RNA. Using the same Thermocycler, 
samples were incubated at 25 oC for 10 minutes, 37 oC for 120 minutes, and 85 oC 
for 5 minutes.  
 Qualitative PolymeraseChain Reaction. Taqman reagents and protocol 
from Applied Biosciences were used for this experiment. The cDNA used was 
diluted to 5ng/µl, and 4µl were used with 2µl of primer, 10µl Taqman Master 
mix, and 4µl of water per reaction, was loaded into a well on a 384-well plate. 
There were 12 samples per construct, and three primers used, and each reaction 
was replicated. The primers measured DRD2 Long, DRD2 Short, and B-Actin, 
and are also found in Figure 1. The plate was then placed into a LightCycler 480 
from Roche Applied Science (Indianapolis, IN). The following incubation cycles 
were used for the reaction: 50
o
C for 2 minutes, 95
o
C for 10 minutes, and 50 
cycles of 95oC for 15s and 60oC for 1 minute. To calculate threshold, a default 
setting called 2
nd
Derivative Maximums was used. 
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Statistical Analysis. Cycle numbers of D2L and D2S were normalized 
using β-Actin (βA )cycle numbers. Ratios were computed using the following 
formula: 
L/S Ratio= 2
-[(D2L- βA) – (D2S- βA)]
 
 
Data included were found within 1.5x Interquartile Range + the upper and lower 
quartile values One value was excluded from sample from construct ATTTT. 
Kolmogorov-Smirnov statistics were used to determine the normality of the L/S 
Ratio results, and a multivariate linear regression model calculated with STATA 
software from StataCorp (College Station, Texas) was used to analyze the 
significance and weights of the various SNPs and the coefficient of the data. 
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III. Results 
 
Postmortem brain tissue samples of identified persons with schizophrenia 
and controls (non-schizophrenic individuals) were used to find the DRD2 genetic 
sequence of these individuals. The brain tissue provided DRD2 DNA for PCR 
amplification of the region from intron 5 to exon 7, and segments were inserted 
into plasmids; thus one patient could yield two constructs with different 
haplotypes from its two natural alleles. Selected subjects varied at four mutation 
sites: rs12363125 with a G or A base pair (bp), rs2511521 with a C or T, rs6275 
with a C or T, and rs6277 with C or T. However, many of the SNPs were linked; 
those with rs12363125A would always have a rs2511521T, and rs6275C would 
always have a rs6277T. Because of this linked heritage, I had to create new 
constructs that would demonstrate the entire spectrum of SNP combinations.  
The exon 7 alleles, rs6275 and rs6277, are only 18 nucleotides apart. Only 
one restriction enzyme had a binding site between these SNPs that could separate 
these two mutations. However, because this enzyme had multiple restriction sites 
on the DRD2 gene and its plasmid vector, more steps had to be taken. First, a 
double digest was produced to excise exon 7 and its surrounding region from the 
patient constructs, while the remainder contained intron 5 which has both 
rs1236125 and rs2511521 sites. Next, the exon 7 fragment was digested to 
separate rs6275 and rs6277. See figure 2. 
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Construct Map: 
Enzyme Cut Sites, Fragments, and SNPs 
 
 
Figure 2. Construct map is provided, with increments of 1000bp shown with the 
first base pair at the start of DRD2 region. SNPs are shown, indicated in red: from 
left to right are allele sites rs12363125, rs2511521, rs6275, and rs6277. The 
fragments produced through enzyme digests are shown in purple, black and blue, 
while the pcDNA vector is shown in green. Orange marks the sites of the 
enzymes used to create constructs. 
  pcDNA 3.1 vector 
  Fragment 1: rs12363125 
  Fragment 2: rs6275 
  Fragment 2: rs6277 
  Enzyme cut Sites 
  SNP site 
Color Key 
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This entire process was done on two reciprocal patient constructs, which 
allowed six different DRD2 profiles to be created through ligation reactions. The 
first segment of the construct would have rs2511521 and rs1236125, the middle 
segment would contain rs6275, and the remaining segment would have rs6277. 
Because the first segment contained both rs2511521 and rs1236125, the alleles 
became linked in the experiment: a “G” at the rs12363125 site was always paired 
with a “C” at the rs2511521 site. Further work could be done to separate the two 
linked loci and ligate them to existing rs6275-rs6277 combinations to provide a 
full compendium of constructs for future experiments. The ligation reactions were 
grown overnight, and colonies were selected and sequenced to confirm ligation 
success. 
Overall, five constructs were created through strategic matching of 
segments from patients with GCTC and ATCT profiles. Because one of the 
potential DRD2 profiles that could have been created through this process was 
actually present in a patient, the patient DNA was used for the ATTC profile 
instead. The original patient DNA used to create the constructs was also included, 
making a total of eight constructs for the experiment (Figure 3).  
The constructs were transfected into cells that were then grown for 48 
hours. The RNA was then harvested from the cells; it was assumed that the 
amount of RNA representing one isoform directly correlated with the quantity of 
the protein isoform that was synthesized or expressed.  Reverse transcriptions and 
quantitative polymerase chain reactions were performed.  
16 
 
 
 
 
DRD2 Experimental Constructs: 
Alleles at the Four Mutation Sites 
 
 
Figure 3. Displayed are the eight constructs (*natural constructs found in patient 
PMB tissue) used in this experiment. The constructs had identical sequences 
besides the alleles at the four SNP sites associated with schizophrenia found in the 
DRD2 gene. 
 
 
 
 
SNPs GCTC* ATTC* ATCT* GCTT GCCC GCCT ATCC ATTT 
rs12363125 G A A G G G A A 
rs2511521 C T T C C C T T 
rs6275 T T C T C C C T 
rs6277 C C T T C T C T 
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For the qPCR, primers were used to amplify Short (D2S) and Long 
isoforms (D2L) of the DRD2 region by using exon-exon boundary specific 
oligonucleotides (D2L primer binding site was at the boundary of exon 6 and 7, 
while  the D2S primer binding site was where exon 5 met exon 7). β- Actin (βA) 
primers acted as the housekeeping gene to control for varying levels of expression 
by HEK cells. It was assumed that the number of cycles it took to reach threshold 
represented the original quantity of RNA present in the cell; thus those that 
reached threshold earlier had more RNA expressed. These data contributed to 
calculating the Long to Short ratios (L/S Ratios) of the DRD2 isoforms. 
The L/S Ratio values were averaged over 12 trials, and the results are shown 
in Figure 4. One data point was excluded as an outlier after performing 
interquartile range calculations; it was a L/S Ratio of 4.155 from construct ATTT. 
The construct with the highest average L/S ratio was GCTC, and the smallest 
average was with construct GCCT. The L/S range of the 95 data samples were 
from 1.564 to 2.420 with a mean of 1.962 and a median of 1.959. The data 
follows a normal distribution with an insignificant Kolmogorov-Smirnov statistic 
(p=.076). See figure 5. 
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Experimental Results: 
 Averaged Long to Short Isoform Ratios 
 
Figure 4.L/S Ratio averages from qPCR for each construct ordered highest to 
lowest. N=12, except for ATTT: N=11. Error bars are constructed by using the 
mean + standard error. 
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Frequency of L/S Ratio Data Points: 
 A Histogram to Determine Normality of Curve 
 
Figure 5.Historgram recording frequency of L/S Ratios from the study with 95 
samples. Computed via Stata 9 sofware. 
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A multiple regression analysis was calculated using rs2511521, rs6275, 
and rs6277 mutation variables (Rs2511521 and rs12363125 are co-linear because 
of the links previously described, thus no individual contribution from one or the 
other mutation could have been identified.) The SNPs in combination were shown 
to significantly affect expressed L/S ratio with F(3, 91), df=94, p<0.0001. The 
coefficient of determination of the model (r
2
) was calculated to be 0.255, which 
indicates that the SNPs account for more than 25% of the variance in the observed 
D2L:D2S expression ratios. 
The combinations of rs2511521 and rs12363125 mutations (GC or AT) 
showed no significant influence on L/S ratio with a coefficient of -0.0149 and 
standard error of 0.156, t=-0.96, and p=0.341.  
Rs6275 and rs6277 showed significant results. The allele at rs6275 had a 
0.793 coefficient, a 0.156 standard error, a 5.09 t value, and a p value of <0.001. 
The allele at rs6277 had a β-coefficient of -0.0312, standard error of 0.156, a t 
value of -2.00, and p=0.048.See figure 6.  
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Multivariate Linear Regression Analysis Results: 
The Relative Contribution of Four Alleles 
SNP Coefficient Std. Err. t P 
rs12363125 -0.0149 0.156 -0.96 0.341 
rs2511521 -0.0149 0.156 -0.96 0.341 
rs6275 0.0793 0.156 5.09 0.000 
rs6277 -0.0312 0.156 -2.00 0.048 
 
Figure 6.Multivariate linear regression model results. Coefficient represents the 
direction and amount of contribution of each SNP, t is the value statistic, while p 
determines the possibility that the data was produced at random. A rs6275T 
significantly increases L/S Ratio while an rs6277T decreases L/S Ratio. There 
were no significant contributions to L/S Ratio from rs12363125 and rs2511521 in 
this study. 
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IV. Discussion 
 
The results suggest that the rs6275 allelotype contributed the most to 
determining DRD2 variant ratios and that rs6275T allele in particular was 
associated with an elevated L/S Ratio. In contrast, the rs6277 T allele was 
associated with a significantly lower L/S Ratio, though its effects are not as 
strong. The rs2511521 and rs112363125 SNPs were not found to significantly 
affect L/S Ratio in this experiment. 
The rs6275 SNP is a synonymous mutation in the DRD2 exon 7. Other 
studies have found it to be associated to schizophrenia (Monahkov et al.2008 and 
Vijayan et al. 2007).  Viajayan et al. measured the behavioral effects of rs6275 
and found those homozygous for the T allele responded well to medication 
(Viajayan et al. 2007). 
The rs6277 allele has also been linked to schizophrenia by more studies 
(Fan et al. 2009, Monakhov et al. 2008, Betcheva et al. 2009, and Lawford et al. 
2005).  The T allele at this site has a protective effect from schizophrenia, though 
it causes decreased D2 synthesis, reduced mRNA stability, and a decreased 
response to upregulation of DRD2 by dopamine (Duan et al. 2003). It was also 
found that healthy humans show decreased striatal binding of D2 with those 
homozygous with the C allele (Hirvonen et al. 2004).  Finally, those with the T 
allele outperformed others in working memory tests (Xu et al. 2007, and 
Rodriguez-Jimenez et al. 2006). 
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 These results are very interesting in conjunction with previous studies. 
Perhaps the altered protein folding pattern caused by rs6277enables more 
expression of the DRD2 short variant. Furthermore, rs6275 has been strongly 
linked to higher L/S ratio, independent of the contribution from the rs6277C 
allele. These observations suggest a complex genetic contribution involved in 
schizophrenia. 
 The next step of this study would be to identify the mechanisms through 
which these mutations affect splicing. The alternative splicing regulators that are 
affected can be determined through comparisons of co-transfections of constructs 
with ASRs to transfections with constructs alone, protein mobility shift assays 
that measure the binding ability of ASRs to mRNA with different genetic profiles 
of DRD2, and research splicing databases can identify ASRs whose binding sites 
are affected by the SNPs. Understanding the mechanisms of DRD2 splicing can 
help unravel a small part of the enigma that is schizophrenia, and bring us closer 
to identifying, preventing, and treating the disorder. 
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VI. Summary 
 
 
Introduction 
 Schizophrenia is a severely debilitating disorder that interferes with the 
ability to think logically, experience emotion, succeed socially, and recognize 
reality. There are many different manifestations of schizophrenia. Some persons 
experience psychosis, which is the experience of delusions or auditory or visual 
hallucinations. Another category of symptoms is extremely disorganized thinking 
and situationally inappropriate behavior. Alternatively, some individuals with 
schizophrenia may become extremely inactive with rigid movements and show 
inappropriate or total lack of emotion(National Institute of Mental Health 2009). 
Schizophrenia affects about 24 million people across the globe, 1.1% of the 
United States population (Tsuang et al. 1997). Schizophrenia typically develops in 
early adulthood and lasts until death. In order to help diagnose, treat, and prevent 
schizophrenia, it is incredibly important to learn the mechanisms of the disease.  
 Genes have been shown to greatly contribute to developing schizophrenia. 
The likelihood of developing schizophrenia increases dramatically if one is 
related to someone with schizophrenia; it is 50% likely that an individual whose 
twin has schizophrenia will also develop it(a much higher likelihood than for 
those in the general population), strengthening the hypothesis that genes 
contribute to the disorder (Faraone et al. 1999). This study focused on genetic 
elements concerning a dopamine receptor related to schizophrenia. 
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 The Dopamine Hypothesis is the belief that schizophrenic symptoms are a 
result of excess dopamine in the brain (Schmidt and Beninger 2006). Dopamine 
(DA) is a neurotransmitter that functions in motivation and reward, mood 
regulation, attention, working memory, and voluntary movement- all related to 
schizophrenia symptoms. It has been implicated in many other neurological and 
psychiatric disorders including Parkinson’s disease, attention-deficit hyperactivity 
disorder (ADHD), and drug abuse. Research has shown that the medications most 
effective for treating schizophrenia symptoms target the dopamine receptor D2 
(DRD2) (Seeman 2006). Receptors are proteins that dopamine molecules bind to, 
and subsequently elicit responses in the cell.  Another important study found that 
the regulation and function of D2 receptors was disrupted in schizophrenic 
patients (Kestler et al. 2001) further justifying our research in dopaminergic 
pathways. 
 Several mutations in the gene that encodes the D2 dopamine receptor, 
DRD2, were found to be strongly associated with schizophrenia.  The genetic 
code is the starting block for cellular protein synthesis. DNA in the nucleus of the 
cell is transcribed into RNA, which is the intermediate substrate used to build 
proteins. RNA must undergo several processes in the cytosol of the cell before it 
can be translated into a protein.  One of these steps is splicing; RNA molecules 
contain exons, which are segments of genetic sequence used directly for protein 
synthesis, and introns, whose functions are currently not well understood. During 
splicing, introns and some exons are removed from the molecule; the differential 
removal of exons causes different variants or isoforms of the RNA, which, 
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subsequently, encodes different proteins. In DRD2, a long isoform (D2L) of the 
protein is made which includes exon 6, whereas a short isoform (D2S) has exon 6 
spliced out of the molecule (Bertolino et al. 2009).  The D2S and D2L receptor 
proteins have different functions and are located on different regions of the 
neuron (Lindgren et al. 2003 and Khan et al. 1998). Furthermore, functional 
magnetic resonance imaging, commonly known as fMRI, studies in humans have 
shown that decreased D2S variant expression (number of protein/RNA present) 
significantly affects working memory performance, an activity where patients 
with schizophrenia typically struggle (Zhang et al. 2007).  
My project aims were to pinpoint which mutations or SNPs in the DRD2 
gene result in a high ratio of DRD2 Long to DRD2 Short expression, or relatively 
lower D2S expression, in order to then clarify the splicing factors that alter DRD2 
splicing by interacting differently with the alternate alleles at these loci. 
 
Methods 
 Postmortem brain tissue samples of identified persons with schizophrenia 
and controls (non-schizophrenics) were used to find the DRD2 genetic sequence 
of these individuals. Selected subjects varied at four mutation sites: rs12363125 
with a G or A base pair (bp), rs2511521 with a C or T, rs6275 with a C or T, and 
rs6277 with C or T. However, many of the SNPs were linked; those with 
rs12363125A would always have rs2511521T, and rs6275C would always have  
rs6277T. Because of this linked heritage, I had to create new constructs that 
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would demonstrate the entire spectrum of SNP combinations (Figure 1). These 
were constructed by taking existing subject DNA and cutting them at strategic 
sites with enzymes. The newly created segments were ligated, or re-attached to 
one another in different ways to create the necessary constructs. With this array of 
constructs, all possible DRD2 mutation combinations were represented. 
Figure 1.Constructs used and their varying combinations of SNPs. 
 To quantify the ratio of D2L and D2S expression, quantitative polymerase 
chain reaction (qPCR) was conducted. This analysis started by transfecting cells 
by inserting a circular genetic ring containing a version of the DRD2 gene into 
them. As these cells grow, they create RNA which then creates the different 
DRD2 isoforms. After two days, we extracted the RNA from the cells; the amount 
of RNA representing one isoform should directly correlate with the amount of that 
protein isoform synthesized or expressed. The RNA was then transformed back 
into cDNA(DNA that only includes exons), via reverse transcription reaction. The 
cDNA was then used for PCR which is a process by which specified gene regions 
are amplified, where in each cycle of the reaction, the cDNA region is replicated, 
thus the number exponentially increases. The primers that enable this reaction 
fluoresce or glow when used, and thus the amount of fluorescence measured by a 
qPCR machine represents the quantity of that gene region in the reaction. If there 
SNPs GCTC* ATTC* ATCT* GCTT GCCC GCCT ATCC ATTT 
rs12363125 G A A G G G A A 
rs2511521 C T T C C C T T 
rs6275 T T C T C C C T 
rs6277 C C T T C T C T 
Comment [SG1]: This is an assumption, right? 
Not demonstrated here… 
Comment [SG2]: Re-word for more clarity. 
Comment [SG3]: Why?  Mention the tags that 
are incorporated into the process. 
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was more D2L from one cell, it would reach a detectable threshold quantity faster. 
These data contributed to calculating the Long to Short ratios (L/SRatios). 
Results 
In my experiment, we ran a qPCR twelve times per sample and found the 
following results displayed in Figure 2. The L/S range of the 95 data samples 
were from 1.564 to 2.420 with a mean of 1.962 and a median of 1.959. There was 
one data point (from construct ATTT) that was a computed outlier, and thus 
deleted from the study. 
 
Figure2. Average Long/Short isoform expression measured from QRT-PCR 
reactions. Data is ordered by highest to lowest L/S ratios. 
  
A multivariate linear regression analysis was calculated to determine the 
relative weight (represented by coefficients) and significance (represented by p-
values) of each mutation to the gene’s L/S Ratio by creating a regression line, or 
formula that would help predict L/S Ratio from assorted SNP combinations. 
Because rs2511521 and rs12363125 were always paired in the study, rs2511521 
Comment [LMP4]: Im not sure if I 
like/understand this correction. 
Comment [SG5]: Data are plural, whereas the 
singular for a data point is “datum” 
Comment [SG6]: Mention the use of a 
housekeeping gene as a means of standardization 
for mRNA quantity. 
Comment [LMP7]: In response to SG21 
amdSG18, I wasn’t sure how detailed I wanted to 
get into techniques. I felt that this information 
might be too specific and confusing for non-
scientists. 
Comment [SG8]: Based on what criteria? 
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(representing both SNPs), rs6275, and rs6277 were analyzed (see Figure 3).  The 
coefficient of determination of the model (r2) was calculated to be 0.255, which 
means that with the regression analysis results, 25.5% of the L/S data can be 
attributed to the combination of SNPs, which is considered a strong relationship 
in biology. The alleles at rs6275 and rs6277 were found to be statistically 
significant in determining L/S Ratios, meaning that the likelihood the data was 
collected merely by chance was p<0.001 and p=0.048, respectively. 
SNP Coefficient 
Std. 
Err. t P 
rs2511521 -0.0149 0.156 -0.96 0.341 
rs6275 0.0793 0.156 5.09 0.000 
rs6277 -0.0312 0.156 -2.00 0.048 
Figure 3.Results from multiple linear regression analysis. 
 
Discussion 
 The results suggest that rs6275 allelotype contributed the most to 
determining DRD2 variant ratios and that the rs6275 T allele in particular was 
associated with an elevated L/S Ratio. In contrast, the rs6277 T allele was 
associated with a significantly lower L/S Ratio, though its effects are not as 
strong. Rs2511521 and rs112363125 were not found to significantly affect L/S 
Ratio in this experiment. 
These results are very interesting in conjunction with previous studies. 
The T allele at the rs6277 site was found to alter protein folding, decrease mRNA 
stability (which affects its ability to persist as a molecule) and decrease overall 
expression (Duan et al. 2003). Perhaps the altered protein folding pattern caused 
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by this mutation enables more expression of the DRD2 short variant. Also, both 
rs6275 (Monahkov et al.2008 and Vijayan et al. 2007) and rs6277 (Fan et al. 
2009, Monakhov et al. 2008, Betcheva et al. 2009,and Lawford et al. 2005) have 
been associated with schizophrenia; their contribution to DRD2 splicing may lead 
us to understand how they are involved in the disease. 
 This study can help launch schizophrenia research down many pathways. I 
plan to further investigate how these mutations alter DRD2 isoform expression by 
looking at splicing regulators, proteins that bind to RNA to help direct splicing. 
Protein mobility shift assay is a technique by which we can determine if a splicing 
regulator protein binds to an RNA sequence. These results can be compared to the 
same sequence with mutations to see if the binding site for the splicing regulator 
is altered. This could help identify what proteins are affected by SNPs, advancing 
treatment of schizophrenia. Understanding the mechanisms of DRD2 splicing can 
help unravel a small part of the enigma that is schizophrenia, and bring us closer 
to identifying, preventing, and treating the disorder. 
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